North Run Capital’s Constellium CSTM Stock Holding History

North Run Capital’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.1M	Buy	93,220 +750	+0.8%	+$8.76K	2.53%	13
2022 Q3	$938K	Buy	92,470 +13,470	+17%	+$179K	1.91%	15
2022 Q2	$1.04M	Buy	79,000 +500	+0.6%	+$7.99K	2.14%	14
2022 Q1	$1.41M	Sell	78,500 -74,000	-49%	-$1.35M	2.08%	15
2021 Q4	$2.73M	Hold	152,500	–	–	2.1%	17
2021 Q3	$2.86M	Sell	152,500 -47,500	-24%	-$915K	2.06%	17
2021 Q2	$3.79M	Sell	200,000 -75,000	-27%	-$1.29M	2.58%	15
2021 Q1	$4.04M	Hold	275,000	–	–	2.98%	13
2020 Q4	$3.85M	Sell	275,000 -55,000	-17%	-$621K	4.47%	9
2020 Q3	$2.59M	Hold	330,000	–	–	2.99%	16
2020 Q2	$2.53M	Sell	330,000 -585,000	-64%	-$4.25M	3.48%	13
2020 Q1	$4.77M	Buy	915,000 +240,000	+36%	+$2.58M	4.79%	10
2019 Q4	$9.04M	Sell	675,000 -60,495	-8%	-$835K	7.11%	5
2019 Q3	$9.35M	Sell	735,495 -246,405	-25%	-$2.9M	7.02%	6
2019 Q2	$9.86M	Sell	981,900 -353,100	-26%	-$3.27M	6.68%	5
2019 Q1	$10.7M	Sell	1,335,000 -345,000	-21%	-$2.95M	6.8%	3
2018 Q4	$11.7M	Buy	1,680,000 +727,600	+76%	+$6.47M	8.84%	3
2018 Q3	$11.8M	Buy	952,400 +120,300	+14%	+$1.41M	5.85%	7
2018 Q2	$8.57M	Sell	832,100 -212,900	-20%	-$2.47M	4.62%	10
2018 Q1	$11.3M	Sell	1,045,000 -255,000	-20%	-$3.11M	6.27%	6
2017 Q4	$14.5M	Sell	1,300,000 -889,089	-41%	-$9.46M	8.86%	4
2017 Q3	$22.4M	Sell	2,189,089 -1,079,424	-33%	-$10.2M	10.55%	3
2017 Q2	$22.6M	Sell	3,268,513 -856,487	-21%	-$5.58M	12.02%	4
2017 Q1	$26.8M	Sell	4,125,000 -1,965,000	-32%	-$14M	9.53%	5
2016 Q4	$35.9M	Sell	6,090,000 -1,265,000	-17%	-$7.73M	10.97%	4
2016 Q3	$53M	Sell	7,355,000 -721,153	-9%	-$4.32M	8.32%	2
2016 Q2	$37.9M	Sell	8,076,153 -47,979	-0.6%	-$246K	6.24%	6
2016 Q1	$42.2M	Hold	8,124,132	–	–	5.78%	7
2015 Q4	$62.6M	Buy	8,124,132 +874,132	+12%	+$6.1M	7.38%	4
2015 Q3	$43.9M	Buy	7,250,000 +2,970,335	+69%	+$24.7M	4.31%	7
2015 Q2	$50.6M	Buy	+4,279,665	New	+$67.3M	4.97%	7

Other funds holding CSTM

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

North Run Capital's CSTM Position: Q4 2022 in Review

North Run Capital increased its Constellium (CSTM) stake by 0.81% in Q4 2022, buying an estimated $8.76K and bringing the position to 93,220 shares worth $1.1M. The position accounts for 2.53% of the portfolio, ranked #13.

North Run Capital first reported a position in CSTM in Q2 2015 and has held it in 31 quarters since. The position peaked at $62.6M in Q4 2015. 184 funds tracked by Wall St. Rank hold CSTM as of Q4 2022.

North Run Capital held 93,220 shares of Constellium worth $1.1M as of Q4 2022.
North Run Capital bought 750 Constellium shares in Q4 2022, an estimated $8.76K.
Constellium made up 2.53% of North Run Capital's portfolio in Q4 2022, its #13 holding.
North Run Capital first reported a position in Constellium in Q2 2015 and has held it in 31 quarters since.
North Run Capital's Constellium position peaked at $62.6M in Q4 2015.
184 funds tracked by Wall St. Rank held Constellium as of Q4 2022.

Based on North Run Capital's 13F filing for Q4 2022, filed 14 Feb 2023.